Evidence map›Paper›PMID 41596117›Full record

ArticleAntioxidants (Basel, Switzerland)2026

Neuroprotective Effect of D-Pinitol Against MPTP-Induced Parkinsonism in C57BL/6J Mice.

María Del Carmen Juárez-Vázquez, María Leonor González-Rivera, Ramsés Maximiliano Ramírez-Martínez, Athzirys Alejandra Melecio-Hernández, Juan C Jiménez-Cruz, Gabriela Josefina López-González, Juan Carlos Barragán-Gálvez, Juan Ramón Zapata-Morales, Judit A Aviña-Verduzco, Angel Josabad Alonso-Castro

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

María Del Carmen Juárez-VázquezDepartment of Pharmacy, Natural and Exact Sciences Division, University of Guanajuato (UG), Guanajuato 36000, Guanajuato, Mexico.ORCID 0000-0001-9066-3120
María Leonor González-RiveraDepartment of Pharmacy, Natural and Exact Sciences Division, University of Guanajuato (UG), Guanajuato 36000, Guanajuato, Mexico.ORCID 0000-0002-7573-9294
Ramsés Maximiliano Ramírez-MartínezDepartment of Pharmacy, Natural and Exact Sciences Division, University of Guanajuato (UG), Guanajuato 36000, Guanajuato, Mexico.
Athzirys Alejandra Melecio-HernándezDepartment of Pharmacy, Natural and Exact Sciences Division, University of Guanajuato (UG), Guanajuato 36000, Guanajuato, Mexico.
Juan C Jiménez-CruzSecretariat of Science, Humanities, Technology, and Innovation (SEHCITI)-Institute of Chemical Biological Research, Michoacan University of San Nicolas de Hidalgo, Morelia 58030, Michoacán, Mexico.
Gabriela Josefina López-GonzálezDepartment of Pharmacy, Natural and Exact Sciences Division, University of Guanajuato (UG), Guanajuato 36000, Guanajuato, Mexico.
Juan Carlos Barragán-GálvezDepartment of Pharmacy, Natural and Exact Sciences Division, University of Guanajuato (UG), Guanajuato 36000, Guanajuato, Mexico.ORCID 0000-0002-8860-118X
Juan Ramón Zapata-MoralesDepartment of Pharmacy, Natural and Exact Sciences Division, University of Guanajuato (UG), Guanajuato 36000, Guanajuato, Mexico.
Judit A Aviña-VerduzcoInstitute of Chemical Biological Research, Michoacan University of San Nicolas de Hidalgo, Av. Francisco J. Múgica, s/n, Edificio B-1, Ciudad Universitaria, Morelia 58030, Michoacán, Mexico.ORCID 0000-0002-1266-5849
Angel Josabad Alonso-CastroDepartment of Pharmacy, Natural and Exact Sciences Division, University of Guanajuato (UG), Guanajuato 36000, Guanajuato, Mexico.ORCID 0000-0003-2660-8156

Funding

Secretariat of Science, Humanities, Technology, and Innovation (SEHCITI) in Mexico through the basic and frontier science program CBF2023-2024-1888
6 · The paper itself

Abstract

Parkinson's disease is the second most common neurodegenerative disease in the world. Natural products can offer a possible option of neuroprotective agents for preventing neurodegenerative diseases. D-Pinitol is a cyclic polyol with anxiolytic and antidepressant effects in acute assays. This work aimed to evaluate the effects of D-Pinitol (10, 50, and 100 mg/kg p.o.) in a chronic reserpine-induced depression model (19 days), using the forced swimming and tail suspension tests in female Balb/c mice, and the neuroprotective effects in an MPTP-induced Parkinsonism model (30 days) in male C57bL/6 mice, using behavioral tests such as wire grip, rotarod, catalepsy, and others. D-Pinitol showed low antidepressant-like effects in the reserpine-induced chronic depression model, compared to amitriptyline (25 mg/kg p.o.). D-Pinitol protected MPTP-treated mice from motor impairment with similar effects to those shown by L-Dopa (25 mg/kg p.o.) as evaluated in different behavioral tests. The inhibition of oxidative stress markers, increase in dopamine levels, and avoidance of apoptosis in neuronal cells were the mechanisms by which D-Pinitol protects MPTP-treated mice from motor impairment.

Indexed as

apoptosiscyclic polyolMPTPneuroprotectiveParkinson’s disease

Identifiers

PMID41596117
PMCPMC12837360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.